epirubicin has been researched along with Recrudescence in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (31.25) | 18.2507 |
| 2000's | 23 (47.92) | 29.6817 |
| 2010's | 10 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, JH; Bu, QA; Cui, T; You, FP; Yuan, QZ | 1 |
| Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A | 1 |
| Fisker, RV; Frøkjær, JB; Iyer, V; Kristensen, SR; Larsen, AC; Mortensen, PB; Møller, B; Thorlacius-Ussing, O; Yilmaz, MK | 1 |
| Cai, R; Fan, Y; Li, Q; Ma, F; Mo, H; Wang, J; Wang, X; Xu, B; Yin, Y; Yuan, P; Zhang, B; Zhang, P; Zheng, S | 1 |
| Ardavanis, A; Basioukas, S; Orphanos, G; Rigatos, G; Skafida, S | 1 |
| Choi, IK; Kim, AR; Kim, JS; Kim, YH; Koo, BH; Lee, JB; Oh, SC; Park, KH; Seo, JH; Shin, SW; Sung, HJ | 1 |
| Çal, Ç; Özen, H; Şahin, H; Tanıdır, Y; Türkeri, L | 1 |
| Gallamini, A; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Soricelli, A | 1 |
| Al Nawakil, C; Beranger, N; Brice, P; Brière, J; de Bazelaire, C; de Kerviler, E; Ertault, M; Franchi, P; Sibon, D; Thieblemont, C | 1 |
| Aström, G; Bergh, J; Brandberg, Y; Carlsson, L; Carstensen, J; Einbeigi, Z; Fernö, M; Hatschek, T; Hellström, M; Lidbrink, E; Linderholm, B; Lindh, B; Loman, N; Malmberg, M; Rotstein, S; Söderberg, M; Sundquist, M; Svensson, H; Walz, TM | 1 |
| Matsuo, T; Miyata, Y; Ohba, K; Sagara, Y; Sakai, H; Takahashi, H; Watanabe, S | 1 |
| Anan, K; Arime, I; Chijiiwa, K; Fujii, T; Hara, S; Imamura, S; Inoue, H; Ishikawa, E; Mitsuyama, S; Nishimura, R; Ohchi, T; Ohkido, M; Ohno, S; Oikawa, T; Shimada, K; Tamura, K; Tanaka, M; Taniguchi, H; Yano, H | 1 |
| Alinari, L; Baccarani, M; Bonifazi, F; Gabriele, A; Molinari, AL; Salvucci, M; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zuffa, E | 1 |
| Bhardwaj, N; Bhutani, M; Kochupillai, V; Kumar, L; Pathak, AK; Singh, R; Vora, A | 1 |
| Colombat, P; Desablens, B; Escoffre, M; Gandhour, C; Haillot, O; Harousseau, JL; Jacob, C; Le Prise, PY; Lefrancq, T; Leloup, R; Linassier, C; Lucas, V; Tabuteau, S | 1 |
| Bouabdallah, R; Brice, P; Brière, J; Le Gouill, S; Lepage, E; Lepretre, S; Morel, P; Raffoux, E; Sebban, C | 1 |
| Anargyrou, K; Angelopoulou, MK; Boussiotis, VA; Boutsis, DE; Dimopoulou, MN; Karkantaris, C; Kokoris, SI; Kontopidou, FN; Kyrtsonis, MC; Michalopoulos, T; Panayiotidis, P; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Tsaftaridis, P; Variamis, E; Vassilakopoulos, TP | 1 |
| Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Chung, KW; Jang, JW; Kim, CW; Lee, CD; Lee, YS; Sun, HS; Yang, JM; Yoon, SK | 1 |
| Cargill, A; Darbyshire, PJ; Eden, T; Hann, I; Lancaster, D; Lim, A; Love, S; Moorman, AV; Roy, A; Saha, V; Stoneham, S | 1 |
| Cree, IA; Di Nicolantonio, F; Di Palma, S; Fernando, A; Gabriel, FG; Glaysher, S; Gulliford, T; Higgins, B; Hurren, J; Johnson, P; Knight, LA; Lamont, A; Mercer, SJ; Sharma, S; Somers, SS; Toh, S; Whitehouse, PA; Yiangou, C | 1 |
| Albarello, A; Ballerini, F; Balocco, M; Canepa, L; Canepa, P; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R | 1 |
| Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lau, YL; Shek, TW | 1 |
| Choi, CW; Jung, KY; Kim, BS; Kim, CY; Kim, IS; Kim, JS; Kim, SJ; Seo, HY; Seol, HR; Sung, HJ | 1 |
| Beishuizen, A; de Man, R; Lam, KH; Pieters, R; van den Heuvel-Eibrink, MM; van Grotel, M | 1 |
| Chen, Y; Cheng, JM; Gong, GQ; Liu, QX; Liu, R; Luo, JJ; Qian, S; Wang, JH; Wang, XL; Yan, ZP | 1 |
| Agrawal, RK; Bathers, S; Brunt, AM; Crawford, SM; Dunn, JA; Earl, HM; Fernando, IN; Foster, L; Grieve, RJ; Harvey, P; Hiller, L; Leonard, RC; Mansi, JL; McAdam, K; O'Reilly, SM; Poole, CJ; Rea, DW; Simmonds, P; Spooner, DA; Stanley, A; Twelves, CJ | 1 |
| Chuma, M; Harabayashi, T; Higashiyama, H; Hige, S; Nonomura, K; Shinohara, N | 1 |
| Alonso, C; Altés, A; Baiget, M; Barnadas, A; Del Rio, E; Paré, L; Ramón y Cajal, T; Sedano, L | 1 |
| Balzarotti, M; Isa, L; Magagnoli, M; Morenghi, E; Santoro, A; Siracusano, LV; Spina, M; Tirelli, U | 1 |
| Aravantinos, G; Bafaloukos, D; Bozas, G; Dimopoulos, MA; Fountzilas, G; Kalofonos, H; Kosmidis, P; Papadimitriou, CA | 1 |
| Arai, Y; Kakehi, Y; Kanba, T; Shichiri, Y; Yoshida, O; Yoshida, S | 1 |
| Anderström, C; Eddeland, A; Folmerz, P; Hansson, R; Milles, S; Zachrisson, B | 1 |
| Hansen, F; Møller, P; Skovsgaard, T | 1 |
| Andreoli, F; Borrelli, D; Bruno, L; Cini, G; de Leonardis, V; Fabbroni, S; Intini, C; Neri, B; Pernice, LM; Romano, S; Valeri, A | 1 |
| Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
| Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S | 1 |
| Advani, SH; Dinshaw, KT; Joshi, SR; Mukhadan, M; Nair, NN; Nair, R; Parikh, PM; Ramakrishnan, G; Saikia, TK; Soman, CS | 1 |
| Chang, KJ; Chang, YS; Chen, YC; Cheng, AL; Lin, DT; Lin, JF; Lin, MT; Lui, LT; Tang, JL; Yeh, KH; Yu, SC | 1 |
| Ashley, S; Atra, A; Kingston, JE; Mott, M; Pinkerton, CR; Shankar, AG | 1 |
| Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
| Darbyshire, PJ; Eden, OB; Harrison, G; Lawson, SE; Oakhill, A; Richards, S; Stevens, R | 1 |
| Alessandroni, P; Antognoli, S; Bascioni, R; Bracci, R; Cellerino, R; Ciavattini, A; De Nictolis, M; Massacesi, C; Piga, A; Scartozzi, M | 1 |
| Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
| Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J | 1 |
| Corselli, G; Pavone, C; Pavone-Macaluso, M; Serretta, V | 1 |
| Bolis, G; Borello, C; Maggi, R; Presti, M; Scarfone, G; Zanaboni, F | 1 |
| Ahrenberg, P; Ala Harja, K; Almqvist, A; Elonen, E; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Jouppila, J; Palva, IP | 1 |
| Bartoli, C; Bonadonna, G; Brambilla, C; Coopmans de Yoldi, G; Ferrari, L; Greco, M; Luini, A; Rilke, F; Veronesi, U; Zucali, R | 1 |
1 review(s) available for epirubicin and Recrudescence
| Article | Year |
|---|---|
Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Topics: Adenoma, Sweat Gland; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Acinar Cell; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parotid Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survivors; Sweat Gland Neoplasms; Vincristine; Whole-Body Irradiation | 2008 |
22 trial(s) available for epirubicin and Recrudescence
| Article | Year |
|---|---|
Observation and analysis of clinical efficacy of breast-conserving therapy integrated with neoadjuvant chemotherapy on Breast Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Docetaxel; Epirubicin; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Postoperative Complications; Quality of Life; Recurrence; Survival Analysis; Treatment Outcome | 2018 |
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Recurrence; Survival Analysis; Treatment Outcome; Triple Negative Breast Neoplasms | 2016 |
Docetaxel and epirubicin salvage regimen in relapsed anthracycline-sensitive metastatic breast cancer patients after anthracycline-containing adjuvant therapy.
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recurrence; Salvage Therapy; Survival Analysis; Taxoids | 2009 |
Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study.
Topics: Administration, Intravesical; Aged; Antibiotics, Antineoplastic; Carcinoma; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Period; Recurrence; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2010 |
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vinblastine | 2011 |
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Recurrence; Treatment Outcome | 2012 |
[Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Recurrence; Taxoids | 2012 |
Randomized study comparing 4'-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence; Survival Analysis; Time Factors | 2002 |
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Recurrence; Testicular Neoplasms; Time Factors; Vincristine | 2002 |
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Recurrence; Retrospective Studies; Virus Activation | 2004 |
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Quality of Life; Recurrence; Survival Analysis | 2006 |
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Endometrial Neoplasms; Epirubicin; Female; Greece; Humans; Injections, Intravenous; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Recurrence | 2008 |
Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Estramustine; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Recurrence | 1995 |
Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cisplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Recurrence; Treatment Outcome | 1996 |
Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Neoplasm Staging; Proportional Hazards Models; Recurrence; Stomach Neoplasms; Survival Rate; Time Factors | 1996 |
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Survival Rate | 1998 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Epirubicin; Humans; Hydrocortisone; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Statistics, Nonparametric; Thioguanine; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vincristine | 2000 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine | 1992 |
Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Recurrence | 1991 |
Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma. Finnish Leukaemia Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Doxorubicin; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Multicenter Studies as Topic; Multiple Myeloma; Prednisolone; Recurrence; Vincristine | 1990 |
25 other study(ies) available for epirubicin and Recrudescence
| Article | Year |
|---|---|
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Female; Humans; Incidence; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Prognosis; Prospective Studies; Pulmonary Embolism; Recurrence; Risk Factors; Stomach Neoplasms; Treatment Outcome; Venous Thrombosis | 2015 |
Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphocytes; Mastectomy, Radical; Recurrence; Skin Diseases; Time Factors; Treatment Outcome | 2008 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Recurrence; Spleen; Tomography, X-Ray Computed; Young Adult | 2011 |
Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cystectomy; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Japan; Male; Methotrexate; Middle Aged; Paclitaxel; Prognosis; Recurrence; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2002 |
Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2003 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United Kingdom; Vincristine | 2005 |
Cancer cell adaptation to chemotherapy.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy; Camptothecin; Cell Line, Tumor; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Therapy; Epirubicin; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Irinotecan; Neoplasms; Paclitaxel; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Topotecan; Treatment Outcome; Up-Regulation | 2005 |
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Multiple Myeloma; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Proportional Hazards Models; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 2006 |
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, B-Cell; Male; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine | 2006 |
[Epirubicin in the treatment of malignant obstructive jaundice].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Jaundice, Obstructive; Liver Neoplasms; Male; Middle Aged; Recurrence; Survival Rate | 2006 |
Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy.
Topics: Antineoplastic Agents; Cisplatin; Epirubicin; Female; Hepatitis B; Humans; Methotrexate; Middle Aged; Recurrence; Urinary Bladder Neoplasms | 2007 |
Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Electrophoresis, Agar Gel; Epirubicin; Female; Fluorouracil; Genotype; Humans; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Predictive Value of Tests; Recurrence; Retrospective Studies; Thymidylate Synthase | 2007 |
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Recurrence | 2007 |
Intra-arterial infusion chemotherapy in combination with a biscoclaurine alkaloid, Cepharanthin, to treat bone metastasis arising from renal cell carcinoma.
Topics: Alkaloids; Angiography; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Biopsy; Bone Neoplasms; Carcinoma, Renal Cell; Epirubicin; Humans; Ilium; Injections, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vinblastine | 1994 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine | 1998 |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Mastectomy, Modified Radical; Middle Aged; Radiotherapy, Adjuvant; Recurrence; Survival Rate | 1998 |
A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Recurrence; Salvage Therapy; Vincristine | 1998 |
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Recurrence; Retrospective Studies; Survival Analysis | 2000 |
A pilot study comparing different dose levels and administration schedules of interferon-alpha 2b combined with epirubicin for prevention of recurrence in bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Humans; Interferon alpha-2; Interferon-alpha; Pilot Projects; Recombinant Proteins; Recurrence; Urinary Bladder Neoplasms | 1992 |
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Recurrence | 1990 |